Priscilla VanderVeer Priscilla VanderVeer is a deputy vice president, public affairs, at PhRMA. Ms. VanderVeer has more than 15 years of experience communicating important health care issues to a wide variety of audiences, including medical, health and patient advocates; policymakers and opinion-leaders; and the general public. At PhRMA, Ms. VanderVeer leads the development and execution of communications strategies and activities for the organization’s key state advocacy priorities. She lives in Silver Spring, Maryland with her husband, Ken and their two dogs: Bea Arthur, a tiny 5 lb. Maltese and Henry, a slightly larger-than-average Yorkshire Terrier.
Recent Posts
SB 17 doesn’t address pressing prescription drug transparency issues for CA voters
By Priscilla VanderVeer | August 30, 2017
California’s SB 17 is one of a number of bills relating to prescription drug transparency around prescription medicine costs that are winding their way through U.S. statehouses.
Read More
17 years (and more) of medical discoveries
By Priscilla VanderVeer | March 24, 2017
Someone asked me recently if donated kidneys last forever. It’s been 17 years and a few days since I received one, which has lasted 17 years longer than I thought it would. That may not be...
Read More
Week in Review: The latest from PhRMA
By Priscilla VanderVeer | May 27, 2016
Threats to multiple myeloma progress – Progress in the fight against multiple myeloma has led to remarkable results, allowing 80 percent of newly diagnosed patients to live more than four years....
Read More
Nearly 4.5 million jobs and counting
By Priscilla VanderVeer | May 17, 2016
At PhRMA, we have the honor of highlighting the hope that America’s biopharmaceutical companies bring to patients in the form of innovative treatments and cures. But beyond the value that...
Read More
Week in Review: The latest from PhRMA
By Priscilla VanderVeer | May 6, 2016
Stopping opioid abuse – PhRMA and its members stand with patients, providers, law enforcement, policymakers and others in calling for and supporting national policies and action to address opioid...
Read More
Week in Review: The latest from PhRMA
By Priscilla VanderVeer | April 29, 2016
Fact Check Friday – When it comes to communications between with payers, biopharmaceutical companies are often constrained in sharing safety and efficacy information about medicines in...
Read More
Week in Review: The latest from PhRMA
By Priscilla VanderVeer | April 15, 2016
Competition works for pricing – Despite misleading claims to the contrary, a new report from IMS Institute for Healthcare Informatics found that net prices for brand medicines increased just 2.8...
Read More
Week in review: The latest from PhRMA
By Priscilla VanderVeer | April 8, 2016
11 years of PPA – This week, we celebrated the 11th anniversary of the Partnership for Prescription Assistance (PPA) by launching a mobile app. The new app will offer a single point of access to...
Read More
Week in Review: The latest from PhRMA
By Priscilla VanderVeer | April 1, 2016
Discriminatory effect of insurance plan structure – New research from Harvard’s Center for Health Law and Policy Innovation (CHLPI) shows evidence that some insurance plans are designed to...
Read More
Week in review: The latest from PhRMA
By Priscilla VanderVeer | March 25, 2016
FDA quality metrics: Building on our constructive ideas for improvements to the FDA’s recent proposal for a mandatory metrics program, we featured a guest blog post from Mairead Goetz, head of...
Read More
Medicare Monday (100)
340B Spotlight (34)
Cost & Consequence (0)
